Next Race


Date Race Broadcast
Aug 03 2014 Honda Indy 200 at Mid-Ohio 3:00 PM ET NBC Sports
View the entire Schedule

Previous Results


Date Race Driver Start Finish Standing
Jul 20 2014 Honda Indy Toronto Race 2 Kanaan
Kimball
Dixon
Briscoe
9
16
7
12
2
4
7
11
8
13
6
11
Jul 19 2014 Honda Indy Toronto Race 1 Kanaan
Dixon
Kimball
Briscoe
5
9
17
21
3
5
7
12
9
7
15
11
Jul 12 2014 Iowa Corn Indy 300 Kanaan
Dixon
Briscoe
Kimball
2
1
4
7
3
4
9
10
10
8
9
16
Jul 06 2014 Pocono INDYCAR 500 Briscoe
Dixon
Kanaan
Kimball
10
15
8
17
4
5
11
17
9
8
11
15
Jun 29 2014 Shell and Pennzoil Grand Prix of Houston Race 2 Kimball
Briscoe
Kanaan
Dixon
19
15
8
11
4
8
10
18
15
13
11
9
Visit INDYCAR.com for more details

Our Drivers


Charlie Kimball completed his third IndyCar Series season in the No. 83 NovoLog FlexPen entry in 2013. He returns to Novo Nordisk Chip Ganassi Racing in 2014 for his fourth season looking to continue to build upon last year’s campaign that saw him score a career-best 10 top-10 finishes and earn his first career win at Mid-Ohio.

Featured News



Novo Nordisk's Partnership: 

Novo Nordisk Chip Ganassi Racing was formed before the 2011 IndyCar Series season with driver Charlie Kimball – a Type-1 diabetic. Novo Nordisk, a world leader in diabetes care returns for a fourth season to continue to raise the level of diabetes awareness in the country and encourage people to talk to their healthcare provider about diabetes. Kimball enters his fourth season as the driver of the No. 83 NovoLog FlexPen Chevrolet and is coming off a season that saw him score a career-best 10 top-10 finishes and earn his first career win at Mid-Ohio.

About Novo Nordisk: 

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in Denmark, Novo Nordisk employs approximately 37,200 employees in 76 countries, and markets its products in more than 180 countries.

Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).

Interested in joining our winning team? 

Learn about the benefits of sponsorship.